The future of health and science is coming into focus across the pond.
On Wednesday, the Mayor of London, Boris Johnson, launched a major new initiative backed by some of the UK’s senior academics and business people that will transform the London-Oxford-Cambridge life sciences sector into a world beating “power-cluster.”
Through MedCity, the mayor says, the life sciences sector in the South East will come to match the crucial position of financial services in the UK’s national economy.
The new organization is tasked with attracting life sciences corporations large and small to the ‘golden triangle’ formed by the three UK cities, facilitating collaboration between them and the UK academic research base, and reinforcing specialist infrastructure so that the region becomes one of the premier, interconnected clusters for life science research, development, manufacturing and commercialization.
“Together with Oxford and Cambridge we form a ‘golden triangle’ of scientific innovation and we need to channel that intellectual pre-eminence into a positive impact on our economy,” says Mayor Johnson. “MedCity will span everything from research to clinical trials to manufacturing, across biotech, med tech and health tech. I am in no doubt that having the whole ‘chain’ from small spin-offs to massive companies doing their research, clinical development and manufacturing here in London and the south east can be as important to our economy as the financial services sector is today.”